These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26957302)

  • 1. Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels-Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance.
    Wang YR; Wang QH; Zhang T; Liu YH; Yao XQ; Zeng F; Li J; Zhou FY; Wang L; Yan JC; Zhou HD; Wang YJ
    Mol Neurobiol; 2017 Apr; 54(3):2338-2344. PubMed ID: 26957302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Amyloid-Beta Levels in Patients with Different Types of Cancer.
    Jin WS; Bu XL; Liu YH; Shen LL; Zhuang ZQ; Jiao SS; Zhu C; Wang QH; Zhou HD; Zhang T; Wang YJ
    Neurotox Res; 2017 Feb; 31(2):283-288. PubMed ID: 27913965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
    Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
    Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease.
    Kirabali T; Rigotti S; Siccoli A; Liebsch F; Shobo A; Hock C; Nitsch RM; Multhaup G; Kulic L
    Acta Neuropathol Commun; 2019 Dec; 7(1):194. PubMed ID: 31796114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
    J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Peripheral Transport Proteins and Plasma Amyloid-β in Patients with Alzheimer's Disease Were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis.
    Gao L; Wang J; Jiang Y; Wei S; Shang S; Chen C; Dang L; Huo K; Deng M; Wang J; Qu Q
    J Alzheimers Dis; 2020; 78(2):699-709. PubMed ID: 33016902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain.
    Swaminathan SK; Ahlschwede KM; Sarma V; Curran GL; Omtri RS; Decklever T; Lowe VJ; Poduslo JF; Kandimalla KK
    J Cereb Blood Flow Metab; 2018 May; 38(5):904-918. PubMed ID: 28569090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.
    Roher AE; Esh CL; Kokjohn TA; Castaño EM; Van Vickle GD; Kalback WM; Patton RL; Luehrs DC; Daugs ID; Kuo YM; Emmerling MR; Soares H; Quinn JF; Kaye J; Connor DJ; Silverberg NB; Adler CH; Seward JD; Beach TG; Sabbagh MN
    Alzheimers Dement; 2009 Jan; 5(1):18-29. PubMed ID: 19118806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
    PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased clearance of CNS beta-amyloid in Alzheimer's disease.
    Mawuenyega KG; Sigurdson W; Ovod V; Munsell L; Kasten T; Morris JC; Yarasheski KE; Bateman RJ
    Science; 2010 Dec; 330(6012):1774. PubMed ID: 21148344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of Abeta42 and Abeta40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrine.
    Basun H; Nilsberth C; Eckman C; Lannfelt L; Younkin S
    Dement Geriatr Cogn Disord; 2002; 14(3):156-60. PubMed ID: 12218259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma amyloid beta levels and platelet mitochondrial respiration in patients with Alzheimer's disease.
    Fišar Z; Jirák R; Zvěřová M; Setnička V; Habartová L; Hroudová J; Vaníčková Z; Raboch J
    Clin Biochem; 2019 Oct; 72():71-80. PubMed ID: 30954436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Level of Plasma Amyloid-β40 Is Correlated with Peripheral Transport Proteins in Cognitively Normal Adults: A Population-Based Cross-Sectional Study.
    Gao L; Jiang Y; Wei S; Shang S; Li P; Chen C; Dang L; Wang J; Huo K; Deng M; Wang J; Zhang R; Qu Q
    J Alzheimers Dis; 2018; 65(3):951-961. PubMed ID: 30103331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults.
    Wei M; Zhao B; Huo K; Deng Y; Shang S; Liu J; Li Y; Ma L; Jiang Y; Dang L; Chen C; Wei S; Zhang J; Yang H; Gao F; Qu Q
    J Alzheimers Dis; 2017; 57(3):899-906. PubMed ID: 28304302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.
    Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y
    Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.